Literature DB >> 15916880

Catenin expression in T1/2 carcinomas of the floor of the mouth.

T Fillies1, H Buerger, C Gaertner, C August, B Brandt, U Joos, R Werkmeister.   

Abstract

Reduction of the expression of catenin is a crucial step in the pathogenesis, progression and prognosis of many epithelial cancers including squamous cell carcinomas (SCCs). Catenin expression in oral carcinomas was evaluated in relation to clinico-pathological features in order to determine its value as a prognostic marker. Eighty-five patients with histologically proven T1/2 squamous cell carcinoma of the oral floor who underwent surgical treatment were eligible for the study. A tissue microarray consisting of multiple representative tissue cores of each carcinoma was composed. The expression levels of alpha, beta and gamma-catenins were determined immunohistologically. Correlation between clinical features and the expression of catenin proteins was evaluated statistically using Kaplan-Meier curves, log-rank tests and chi(2)-tests. Loss of alpha-catenin expression in carcinoma of the floor of the mouth correlated significantly with poor prognosis (P=0.05). Conversely, significantly reduced rates of lymph-node metastases were observed in alpha- and beta-catenin-positive T1 and T2 SCCs. Loss of gamma-catenin expression indicated a reduced survival rate in nodal-negative tumours (P=0.02). Catenin expression in carcinomas of the floor of the mouth seems to be a predictive parameter in the prognosis of T1 and T2 SSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916880     DOI: 10.1016/j.ijom.2005.03.010

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  6 in total

1.  Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.

Authors:  Marianthi Kyrodimou; Dimitrios Andreadis; Angeliki Drougou; Elsa P Amanatiadou; Lefteris Angelis; Calypso Barbatis; Apostolos Epivatianos; Ioannis S Vizirianakis
Journal:  Clin Oral Investig       Date:  2013-02-22       Impact factor: 3.573

2.  Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.

Authors:  Partheeban Balasundaram; Manoj Kumar Singh; Amit Kumar Dinda; Alok Thakar; Rajni Yadav
Journal:  Diagn Pathol       Date:  2014-07-21       Impact factor: 2.644

3.  Site-specific gene expression patterns in oral cancer.

Authors:  Gesche Frohwitter; Horst Buerger; Eberhard Korsching; Paul J van Diest; Johannes Kleinheinz; Thomas Fillies
Journal:  Head Face Med       Date:  2017-05-10       Impact factor: 2.151

4.  SPINK7 expression changes accompanied by HER2, P53 and RB1 can be relevant in predicting oral squamous cell carcinoma at a molecular level.

Authors:  Gina Pennacchiotti; Fabio Valdés-Gutiérrez; Wilfredo Alejandro González-Arriagada; Héctor Federico Montes; Judith Maria Roxana Parra; Valeria Andrea Guida; Silvina Esther Gómez; Martin Eduardo Guerrero-Gimenez; Juan Manuel Fernandez-Muñoz; Felipe Carlos Martin Zoppino; Rubén Walter Carón; Marcelo Eduardo Ezquer; Ricardo Fernández-Ramires; Flavia Alejandra Bruna
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

Review 5.  Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Pablo Ramos-García; Miguel Á González-Moles
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

6.  Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways.

Authors:  Gesche Frohwitter; Horst Buerger; Paul J VAN Diest; Eberhard Korsching; Johannes Kleinheinz; Thomas Fillies
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.